Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OR/Eugene
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Eugene, OR

Studies commonly pay $75 to $4,500 per completed study

148 clinical trials are currently recruiting participants within 30 miles of Eugene. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

148studies recruiting
9+research centers nearby
1condition categories
Live from the NIH registry

Studies recruiting near Eugene right now

Top 25 of 148 recruiting studies, sorted by proximity — each links to its official registry page

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Urothelial Cancer, Advanced/Metastatic Urothelial Cancer Phase 1, Phase 2 Interventional 132 participants sought
Oncology Associates of Oregon, P.C. — Eugene, Oregon (1.6 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07421700)

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Cervical Cancer Phase 3 Interventional 1,023 participants sought
Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8007) — Eugene, Oregon (1.6 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT07216703)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy, Macular Degeneration Phase 2 Interventional 274 participants sought
Verum Research LLC — Eugene, Oregon (1.6 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06635148)

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Verum Research, LLC — Eugene, Oregon (1.6 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Urothelial Cancer, Urinary Bladder Neoplasms Phase 3 Interventional 390 participants sought
Williamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07566156)

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Breast Cancer N/A Observational 30,000 participants sought
Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi) · Sponsor: Agendia
See eligibility & contact on ClinicalTrials.gov (NCT03053193)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant Phase 3 Interventional 800 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07225946)

Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network

Genetic Disease N/A Observational 20,000 participants sought
University of Oregon — Eugene, Oregon (1.6 mi) · Sponsor: National Human Genome Research Institute (NHGRI)
See eligibility & contact on ClinicalTrials.gov (NCT02450851)

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
Oncology Associates of Oregon, P.C. — Eugene, Oregon (1.6 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07144280)

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

Clinical High Risk for Psychosis (CHR) Phase 1, Phase 2 Interventional 150 participants sought
Prevention Science Institute — Eugene, Oregon (1.6 mi) · Sponsor: Monument Therapeutics Limited
See eligibility & contact on ClinicalTrials.gov (NCT07226895)

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

High-Risk Non-Muscle-Invasive Bladder Cancer Phase 2 Interventional 325 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi) · Sponsor: CG Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06567743)

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 270 participants sought
517 — Eugene, Oregon (1.6 mi) · Sponsor: Corcept Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06906341)

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer Phase 1, Phase 2 Interventional 884 participants sought
USOR Oncology Associates of Oregon, P.C. — Eugene, Oregon (1.6 mi) · Sponsor: Genmab
See eligibility & contact on ClinicalTrials.gov (NCT05579366)

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 100 participants sought
Oncology Associates of Oregon, P.C — Eugene, Oregon (1.6 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06806033)

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer Phase 3 Interventional 330 participants sought
Willamette Valley Cancer Institute and Research Center - Eugene — Eugene, Oregon (1.6 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07005128)

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Non-Muscle Invasive Bladder Neoplasms Phase 3 Interventional 220 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06919965)

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy Phase 1, Phase 2 Interventional 104 participants sought
Oregon Retina- Site Number : 8400017 — Eugene, Oregon (1.6 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07215234)

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung Phase 2 Interventional 480 participants sought
Oncology Associates of Oregon PC Willamette Valley Cancer Institute — Eugene, Oregon (1.6 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06667076)

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
Willamette Valley Cancer Institute — Eugene, Oregon (1.6 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07007312)

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Phase 1, Phase 2 Interventional 606 participants sought
Oncology Associates of Oregon — Eugene, Oregon (1.6 mi) · Sponsor: Sumitomo Pharma America, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04988555)
Actively enrolling

Studies you may be able to join near Eugene

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Eugene

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Willamette Valley Cancer Institute and Research Center - Eugene

★ 4.2 (87 reviews)
520 Country Club Rd, Eugene, OR 97401
(541) 683-5001
"Dr's & nurses are great but they seem super disorganized! They keep changing my son's infusion times. Nobody has called about getting his port. Monda…"
— Jennifer Hernandez, 2★

University of Oregon Prevention Science Institute

University of Oregon, 1600 Millrace Dr, Eugene, OR 97403
(541) 346-3630

The Alliance for Community Wellness

★ 4.6
1195 City View St, Eugene, OR 97402
(541) 342-5394
"They came across to me like people who really care about other people.They listen to me and they've offered me help.I feel very blessed to have found…"
— Jared Watts, 5★

Robert and Beverly Lewis Integrative Science Building

★ 5.0
University of Oregon, Eugene, OR 97401

Benson Health Clinic

★ 3.2 (40 reviews)
66 Club Rd Ste 140, Eugene, OR 97401
(541) 345-1722
"I've worked with Dr. Lumos for a few years and have had great support in sessions! Kind, empathetic, and flexible. Solid front desk staff, though I'v…"
— Jade, 4★

OHSU Child Development and Rehabilitation Center, Eugene

★ 3.1
74 B Centennial Loop STE 100, Eugene, OR 97401
(503) 346-1640
"Been on a supposed waitlist for well over a year to get my son seen. They told my son’s doctor they called several times and I never answered. Though…"
— Mary Bates, 1★

Oregon Social Learning Center

★ 4.4
10 Shelton Mcmurphey Blvd, Eugene, OR 97401
(541) 485-2711

Willamette Valley Cancer Institute and Research Center - Springfield

★ 3.3 (3 reviews)
3355 Riverbend Dr #240, Springfield, OR 97477
(541) 683-5001
"The organization is lacking and has made me feel uncared for due to what seems to be a lack of accountability. Although I've received apologies, ther…"
— C M, 1★

Lewis Integrative Science Building

1440 Franklin Blvd, Eugene, OR 97403

Clinical trials in Eugene: what's recruiting

The Eugene area currently has 148 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Eugene, the most active research areas are:

  • Cancer & Oncology14 studies

Every listing shows the study phase, the recruiting site and its distance from Eugene, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Eugene

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Eugene participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Eugene?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Eugene safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Eugene?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Eugene?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Eugene.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Eugene typically complete one or two studies per year.

Paid clinical trials near Eugene

Other metros within reach

Salem, OR116 Portland, OR1,021 Vancouver, WA1,021 Medford, OR36 Olympia, WA234 Tacoma, WA1,464 Bremerton, WA1,481 Seattle, WA1,510

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Eugene Bladder Issues Due To Spinal Cord Injury in Eugene All conditions

More of OR

Portland1,021 Salem116 Medford36

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts